Blog | Percayai

ALL ARTICLES

df2e23_301a2ad879f146ca83acd9cb2761c3b9~

PercayAI and Saint Louis University Partner to Accelerate AI Adoption across Biomedical Sciences Research

February 2, 2021

Biotech start-up PercayAI and St. Louis University (SLU) announced a partnership to provide SLU researchers with access to PercayAI’s augmented intelligence (AI) drug discovery platform.

Ask the Expert: AI & Machine Learning in Life Sciences – Just Another Model?

December 10, 2020

We’re back with part 2 of our question and answer session with Dr. Dan Kuster, an expert in machine learning and AI. Dan will walk us through understanding AI and machine learning workflows in a biological context.

Ask the Expert: AI and Machine Learning in Biology

October 14, 2020

We’re doing a question and answer session with Dr. Dan Kuster, the CEO and founder of Cambrio, a digital R&D lab focused on life sciences. Dan will walk us through understanding AI and ML workflows in a biological context.

ALS Part III: Using mouse models to understand ALS

August 10, 2020

We use our concept-level comparison tool to identify aspects of the mouse ALS model that are conserved in human familial ALS.

Exploring ALS with AI Part II: Understanding familial and sporadic ALS

July 30, 2020

For part II of our ALS series, we look at the differences and commonalities between two types of ALS: familial and sporadic.

Exploring Amyotrophic Lateral Sclerosis with PercayAI’s AI Tools

July 20, 2020

To kick off our ALS series, we used PercayAI's newest feature, BioExplorer, to generate a visual, interactive, on-demand literature review describing the major mechanisms, therapeutics, and clinical information on ALS

Clinical Proteomics in COVID-19 Infection

July 6, 2020

We analyzed the data from a clinical proteomics study of COVID-19 patients to investigate the biological roles of potential biomarkers.

Using Transcriptomics to Investigate Cardiovascular Risk Factors for COVID-19

June 24, 2020

We analyzed the data from a study on transcriptomic profiles of COVID-19 patients to investigate the cardiovascular risk factors using augmented intelligence (AI) tool.

Go from data to knowledge faster: free webinar

May 26, 2020

We’ll walk you through using CompBio to speed up your omics data analysis, hypothesis generation, and target identification time in this free webinar, Thursday, May 28.

CORD-19 vs. PubMed: How to get the most from COVID-19 knowledge sources

May 8, 2020

We are using our augmented intelligence knowledge mapping tools to quickly ingest information surrounding COVID-19. Here, we analyze and compare two COVID-19 data sources: CORD-19 and PubMed.

Part 2: COVID-19 in Patients: A Transcriptomic Profile

May 6, 2020

We focus on the PBMC samples from the previous transcriptomic study of COVID-19 patients to identify processes that are up- or down-regulated by the infection.

COVID-19 in Patients: A Transcriptomic Profile

April 28, 2020

We analyzed the data from a study on transcriptomic profiles of COVID-19 patients using augmented intelligence (AI) tool and share our findings.